Jennifer Nuzzo, DrPH
Biography
Jennifer Nuzzo is a nationally and globally recognized leader on global health security, public health preparedness and response, and health systems resilience. Together with colleagues from the Nuclear Threat Initiative and Economist Impact, she co-leads the development of the first-ever Global Health Security Index, which benchmarks 195 countries’ public health and healthcare capacities and capabilities, their commitment to international norms and global health security financing, and socioeconomic, political, and environmental risk environments.
In addition to her scholarly work, Nuzzo regularly advises national governments and for-profit and nonprofit organizations on pandemic preparedness and response, including during the COVID-19 pandemic. She was elected to the National Academy of Medicine (NAM) in 2024 and the American Academy of Arts and Sciences (AAAS) in 2025. She is currently a member of the National Academies of Sciences, Engineering and Medicine’s (NASEM) Standing Committee for the Centers for Disease Control and Prevention (CDC) Center for Preparedness and Response. She served as a pandemic advisor for ImpactAssets’ Stop the Spread Campaign.
Her articles have appeared in The New York Times, The Washington Post, USA Today, Fox News, Politico, The Hill, and The Boston Globe. She was featured in Debunking Borat, a television series on Amazon Prime Video, and her work was featured on Last Week Tonight with John Oliver. She served as COVID Advisor for the Borat Subsequent Moviefilm.
Recent News
CDC adds 177 cases to US measles total but has yet to confirm deaths in Pennsylvania
In Bangladesh, hospitals and community health workers are facing an unrelenting battle against measles. Despite increased vaccination rates, cases have surged into the deadliest outbreak the South Asian country has seen since 2005.
---
A 40-year-old woman died on Saturday, the Jefferson County Coroner’s Office has confirmed. Greg Furlong, the coroner, said in a statement, "This is a heartbreaking loss for the family and an unfortunate reminder that measles can be a serious and potentially life-threatening disease."
---
The vaccine, Ervebo (Merck), is licensed for a different species of Ebola than the one causing the outbreak, but early nonclinical data show it may provide some cross-protection against the currently circulating strain.
---